Marshall Wace
MBOT icon

Marshall Wace’s Microbot Medical MBOT Stock Holding History

Marshall Wace’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
+481,045
New +$1.07M ﹤0.01% 2063

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace's MBOT Position: Q1 2026 in Review

Marshall Wace opened a new position in Microbot Medical (MBOT) in Q1 2026: 481,045 shares worth $1.16M. The stake represents ﹤0.01% of the portfolio and ranks #2063 among its holdings.

79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Marshall Wace held 481,045 shares of Microbot Medical worth $1.16M as of Q1 2026.
  • Microbot Medical was a new Marshall Wace position in Q1 2026.
  • Microbot Medical made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2063 holding.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.